← Leaderboards
Younghoon Kwon
University Of Washington
$4,506,335
Attributed
$4,771,258
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,771,258 · 5
By mechanism
R01$3,481,554 · 1
R21$1,289,704 · 4
Top collaborators
- Oguz Akbilgic2 shared
- Ali Azarbarzin2 shared
- Min-Woong Sohn2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Timothy Chilton Cox$8,759,479
- Lori J Leibold$13,140,233
- Ellen A Schur$16,348,643
- David L Tirschwell$8,538,743
- Wt Longstreth$6,269,140
Others in their field
Other Emerging Leaders on “Event”
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ted Ross · University Of Georgia$70,992,558
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Olwen Hahn · Brigham And Women'S Hospital$36,805,199
Research focus
EventPhysiologicalSleepObstructive Sleep ApneaCardiovascular Risk FactorCardiovascular SystemPolysomnographyIndexingInvestigationResponseLinkSleep Apnea SyndromesCardiovascular DiseasesRisk StratificationBlood PressureEvaluationMeasurementApneaAffectSleep DisordersPhysiologic PulseDecision MakingCardiovascular HealthMorbidity - Disease Rate
Grant awards (14)
Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea$573,309
R01 · FY2025 · HL · contact PI
Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea$520,919
R01 · FY2025 · HL · contact PI
Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea$584,601
R01 · FY2024 · HL · contact PI
Deep learning of awake and sleep electrocardiography to identify atrial fibrillation risk in sleep apnea$92,786
R21 · FY2024 · HL · contact PI
Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea$602,391
R01 · FY2023 · HL · contact PI
Deep learning of awake and sleep electrocardiography to identify atrial fibrillation risk in sleep apnea$108,976
R21 · FY2023 · HL · contact PI
Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea$616,173
R01 · FY2022 · HL · contact PI
Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea$584,161
R01 · FY2021 · HL · contact PI
Photoplethysmography Analysis to Assess Cardio-Cerebrovascular Impact of Sleep$273,213
R21 · FY2021 · AG · contact PI
Cardiovascular implications of sleep characteristics using real-world objective sleep data$123,101
R21 · FY2021 · HL · contact PI
Photoplethysmography Analysis to Assess Cardio-Cerebrovascular Impact of Sleep$256,550
R21 · FY2020 · AG · contact PI
Cardiovascular implications of sleep characteristics using real-world objective sleep data$137,730
R21 · FY2020 · HL · contact PI
Pulse Transit Time and Blood Pressure Trends during Sleep as Novel Cardiovascular Markers$133,523
R21 · FY2018 · HL · contact PI
Pulse Transit Time and Blood Pressure Trends during Sleep as Novel Cardiovascular Markers$163,825
R21 · FY2017 · HL · contact PI